Maria Brattsand
Umea, AC, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction: Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer.
Journal: Scientific reports
Published: July 15, 2026
MicroRNA profiles of prostate cancer bone metastases and miR-375 as an inhibitor of the aggressive metastasis subtype MetB.
Journal: Scientific reports
Published: January 29, 2026
Pro-neuropeptide Y as a circulating biomarker for poor prognosis in prostate cancer.
Journal: Scientific reports
Published: January 14, 2026
KLK4T2 Is a Hormonally Regulated Transcript from the KLK4 Locus.
Journal: International journal of molecular sciences
Published: October 20, 2021
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer.
Journal: Clinical epigenetics
Published: February 08, 2021
A Versatile and Robust Serine Protease Inhibitor Scaffold from Actinia tenebrosa.
Journal: Marine drugs
Published: October 29, 2019
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.
Journal: The Prostate
Published: June 27, 2019
Potent, multi-target serine protease inhibition achieved by a simplified β-sheet motif.
Journal: PloS one
Published: November 21, 2018
Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion.
Journal: Molecular oncology
Published: February 21, 2017
Missing factors in human skin equivalent models?
Journal: The British journal of dermatology
Published: January 18, 2017
Last Updated: 09/26/2026